Becton Dickinson & Co.

Becton Dickinson & Co.
Stock Exchange Frankfurt Stock Exchange
EPS
EUR2.89
Market Cap
EUR60.99 B
Shares Outstanding
267.56 M
Public Float
198.63 M
Becton Dickinson & Co.
Stock Exchange New York Stock Exchange
EPS
$3.37
Market Cap
$68.57 B
Shares Outstanding
269.73 M
Public Float
268.1 M

Profile

Address
1 Becton Drive
Franklin Lakes New Jersey 07417
United States
Employees -
Website http://www.bd.com
Updated 07/08/2019
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences.

Financials

View All
Created with Highcharts 5.0.14Becton Dickinson & Co.Net Income. Fiscal year is October-September. All values USD Millions.9299291 1851 1856956959769761 1001 100311311201320142015201620172018025050075010001250
Created with Highcharts 5.0.14Becton Dickinson & Co.Sales/Revenue. Fiscal year is October-September. All values USD Millions.8 0548 0548 4468 44610 28210 28212 48312 48312 09312 09315 98315 98320132014201520162017201805k10k15k20k

Vincent A. Forlenza
Chairman & Chief Executive Officer
Jeffrey William Henderson
Director